CanadaBis Capital Inc. (CNADF)
OTCMKTS · Delayed Price · Currency is USD
0.0625
-0.0005 (-0.79%)
At close: Apr 10, 2025
CanadaBis Capital Market Cap
CanadaBis Capital has a market cap or net worth of $4.00 million as of September 23, 2025. Its market cap has decreased by -47.14% in one year.
Market Cap
4.00M
Enterprise Value
10.51M
Revenue
12.42M
Ranking
n/a
PE Ratio
79.12
Stock Price
$0.06
Market Cap Chart
Since April 30, 2019, CanadaBis Capital's market cap has decreased from 39.78M to 4.00M, a decrease of -89.93%. That is a compound annual growth rate of -30.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2025 | 4.00M | -24.23% |
| Dec 31, 2024 | 5.28M | -80.20% |
| Dec 29, 2023 | 26.70M | 229.33% |
| Dec 30, 2022 | 8.11M | 36.00% |
| Dec 31, 2021 | 5.96M | -43.92% |
| Dec 31, 2020 | 10.63M | -29.05% |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 791.41M |
| Tian'an Technology Group | 728.29M |
| Elite Pharmaceuticals | 667.60M |
| Glass House Brands | 551.67M |
| Northwest Biotherapeutics | 376.65M |
| Nika Pharmaceuticals | 370.64M |
| CytoDyn | 367.01M |
| American Oncology Network | 347.09M |